Outcome comparisons for MDS-CMML and MP-CMML. Kaplan-Meier plots for OS (A) and cumulative incidence of AML (B) in treatment-naïve patients stratified by WHO 2008 and 2017 WBC count (FAB-based MP and MDS subgroups)–based subgroups.